Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2312]
News [3028]
Articles [343]
Editorials [54]
Conferences [200]
elearning [126]
Expert insight: The basic medical understanding of neutropenia and general...
Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland
Expert insight: The basic medical understanding of neutropenia and general clinical considerations ( Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland )
3 Jul 2018
MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs
Prof Jean Klastersky and Prof Bernardo Rapoport
MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs ( Prof Jean Klastersky and Prof Bernardo Rapoport )
3 Jul 2018
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018
Half of CLL patients who relapse on ibrutinib harbour BTK/PLCG mutations
Dr Lydia Scarfo - San Raffaele Scientific Institute, Milan, Italy
Half of CLL patients who relapse on ibrutinib harbour BTK/PLCG mutations ( Dr Lydia Scarfo - San Raffaele Scientific Institute, Milan, Italy )
17 Jun 2018
Venetoclax in patients with previously treated WM
Prof Jorge Castillo - Dana-Farber Cancer Institute, Boston, USA
Venetoclax in patients with previously treated WM ( Prof Jorge Castillo - Dana-Farber Cancer Institute, Boston, USA )
17 Jun 2018
ICLL07 FILO study: Minimal residual disease still detectable after first line...
Prof Pierre Feugier - University of Lorraine, Nancy, France
ICLL07 FILO study: Minimal residual disease still detectable after first line combination therapy ( Prof Pierre Feugier - University of Lorraine, Nancy, France )
17 Jun 2018
Even late progressors with high risk factors in PRIMA prognostic index are more...
Prof Marek Trněný - Charles University, Prague, Czech Republic
Even late progressors with high risk factors in PRIMA prognostic index are more likely to die ( Prof Marek Trněný - Charles University, Prague, Czech Republic )
17 Jun 2018
Patient relevant outcomes and advocacy
Jan Geissler - CML Advocates Network, EuroBloodNET ePAG
Patient relevant outcomes and advocacy ( Jan Geissler - CML Advocates Network, EuroBloodNET ePAG )
17 Jun 2018
The mutational landscape of AML
Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany
The mutational landscape of AML ( Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany )
17 Jun 2018
Lymphoma guidelines in Venezuela
Dr Maria Alejandra Torres Viera - Clínica Santa Sofía, Caracas, Venezuela
Lymphoma guidelines in Venezuela ( Dr Maria Alejandra Torres Viera - Clínica Santa Sofía, Caracas, Venezuela )
16 Jun 2018
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma
Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma ( Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain )
16 Jun 2018
EHA 2018: Research, collaboration and working towards cures
Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland
EHA 2018: Research, collaboration and working towards cures ( Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland )
16 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation